- Home
- GERN vs HRTG Comparison
GERN vs HRTG Comparison
Compare GERN & HRTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GERN | HRTG |
|---|---|---|
| Founded | 1990 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 753.3M | 898.0M |
| IPO Year | 1996 | 2014 |
Fundamental Metrics
Financial Performance| Metric | GERN | HRTG |
|---|---|---|
| Price | $1.37 | $28.99 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 3 |
| Target Price | $3.00 | ★ $32.50 |
| AVG Volume (30 Days) | ★ 6.7M | 306.6K |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 98.61 |
| EPS | N/A | ★ 4.83 |
| Revenue | $183,403,000.00 | ★ $842,277,000.00 |
| Revenue This Year | $147.42 | $5.45 |
| Revenue Next Year | $39.42 | $7.27 |
| P/E Ratio | ★ N/A | $6.16 |
| Revenue Growth | ★ 522.13 | 6.12 |
| 52 Week Low | $1.04 | $9.89 |
| 52 Week High | $3.68 | $31.98 |
Technical Indicators
Market Signals| Indicator | GERN | HRTG |
|---|---|---|
| Relative Strength Index (RSI) | 57.62 | 51.75 |
| Support Level | $1.30 | $28.59 |
| Resistance Level | $1.37 | $30.20 |
| Average True Range (ATR) | 0.08 | 1.05 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 64.58 | 57.13 |
Price Performance
Historical ComparisonAbout GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About HRTG Heritage Insurance Holdings Inc.
Heritage Insurance Holdings Inc is a regional property and casualty insurance company that offers a variety of personal and commercial insurance products. Through its subsidiaries, Heritage Property & Casualty Insurance, Narragansett Bay Insurance, and Zephyr Insurance, the company issues personal residential property insurance in various states in the United States. It also offers commercial residential insurance predominantly for its Florida properties. Heritage Insurance manages insurance underwriting, customer services, actuarial analysis, distribution, and claims processing internally. Company operates in Alabama, California, Connecticut, Delaware, Florida, Georgia, Hawaii, Maryland, Massachusetts, Mississippi, New Jersey, New York, North Carolina, Rhode Island, South Carolina.